Dexamethasone blocks astroglial differentiation from neural precursor cells

NeuroReport

Volumn 17, Issue 16, 2006, Pages 1719-1723

  Sabolek, Michael ^a   Herborg, Anna ^a   Schwarz, Johannes ^b,d   Storch, Alexander ^c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Dexamethasone; Glial differentiation; Neural stem cells; Neuronal differentiation; Nuclear factor B pathway

Indexed keywords

DEXAMETHASONE; GALACTOSYLCERAMIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SN 50; TYROSINE 3 MONOOXYGENASE; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; DRUG EFFECT; ENZYME INHIBITION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; DOPAMINE; EMBRYO; GLUCOCORTICOIDS; INTERLEUKIN-1BETA; MESENCEPHALON; NEURONS; NF-KAPPA B; RATS; RATS, WISTAR; STEM CELLS;

EID: 33750366872     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000236862.08834.50     Document Type: Article

References (25)

1. Hermann A, Gerlach M, Schwarz J, Storch A. Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration. Expert Opin Biol Ther 2004; 4:131-143.
2. Storch A, Paul G, Csete M, Boehm BO, Carvey PM, Kupsch A, et al. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 2001; 170:317-325.
3. Ling ZD, Potter ED, Lipton JW, Carvey PM. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 1998; 149:411-423.
4. Storch A, Lester HA, Boehm BO, Schwarz J. Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells. J Chem Neuroanat 2003; 26:133-142.
5. Bird TA, Sleath PR, deRoos PC, Dower SK, Virca GD. Interleukin-1 represents a new modality for the activation of extracellular signal-regulated kinases/microtubule-associated protein-2 kinases. J Biol Chem 1991; 266:22661-22670.
6. Stylianou E, O'Neill LA, Rawlinson L, Edbrooke MR, Woo P, Saklatvala J. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J Biol Chem 1992; 267:15836-15841.
7. Nam SY, Chung HY. The suppression of radiation-induced NF-kappaB activity by dexamethasone correlates with increased cell death in vivo. Biochem Biophys Res Commun 2005; 336:603-608.
8. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995; 376:167-170.
9. Robinson RS, Mann GE, Gadd TS, Lamming GE, Wathes DC. The expression of the IGF system in the bovine uterus throughout the oestrous cycle and early pregnancy. J Endocrinol 2000; 165:231-243.
10. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270:14255-14258.
11. Lin YC, Brown K, Siebenlist U. Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. Proc Natl Acad Sci USA 1995; 92:552-556.
12. Johe KK, Hazel TG, Muller T, Dugich-Djordjevic MM, McKay RD. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev 1996; 10:3129-3140.
13. Riaz SS, Jauniaux E, Stern GM, Bradford HF. The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro. Brain Res Dev Brain Res 2002; 136:27-34.
14. Parker LC, Luheshi GN, Rothwell NJ, Pinteaux E. IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice. Br J Pharmacol 2002; 136:312-320.
15. Korzhevskii DE, Gilerovich EG, Khozhai LI, Grigor'ev IP, Otellin VA. Modification of histogenetic processes in rat nervous tissue after administration of dexamethasone during prenatal development. Neurosci Behav Physiol 2006; 36:537-539.
16. Fujita T, Fukuyama R, Enomoto H, Komori T. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2. J Cell Biochem 2004; 93:374-383.
17. Tong Q, Zheng L, Lin L, Li B, Wang D, Huang C, et al. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway. Respir Res 2006; 7:37.
18. Kim HR, Cho ML, Kim KW, Juhn JY, Hwang SY, Yoon CH, et al. Upregulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford) 2006; doi:10.1093/rheumatology/kel 159.
19. Alaniz L, Garcia MG, Gallo-Rodriguez C, Agusti R, Sterin-Speziale N, Hajos SE, et al. Hyaluronan oligosaccharides induce cell death through PI3-K/Akt pathway independently of NF-kappaB transcription factor. Glycobiology 2006; 16:359-367.
20. Kramer KK, Liu J, Choudhuri S, Klaassen CD. Induction of metallothionein mRNA and protein in murine astrocyte cultures. Toxicol Appl Pharmacol 1996; 136:94-100.
21. Avola R, Di Tullio MA, Fisichella A, Tayebati SK, Tomassoni D. Glial fibrillary acidic protein and vimentin expression is regulated by glucocorticoids and neurotrophic factors in primary rat astroglial cultures. Clin Exp Hypertens 2004; 26:323-333.
22. Weir MD, Thomas DG. Effect of dexamethasone on glutamine synthetase and glial fibrillary acidic protein in normal and transformed astrocytes. Clin Neuropharmacol 1984; 7:303-306.
23. Shpetner H, Joly M, Hartley D, Corvera S. Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J Cell Biol 1996; 132:595-605.
24. Almawi WY, Melemedjian OK, Rieder MJ. An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin Transplant 1999; 13:365-374.
25. Pousset F, Cremona S, Dantzer R, Kelley K, Parnet P. Interleukin-4 and interleukin-10 regulate IL1-beta induced mouse primary astrocyte activation: a comparative study. Glia 1999; 26:12-21.